MarketPeel
Insider Trading Intelligence
JD

Joshua R. Disbrow

AYTU
CHIEF EXECUTIVE OFFICER · AYTU BIOPHARMA, INC · CIK 0001566240
FILING MIX · LIFETIME93%/7%
BUYS
13
SELLS
1
TOTAL VALUE
$275.9K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
184,703
AVG SELL PX
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Joshua R. Disbrow, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+0.00%-8.20%-0.15%-8.05%-6.66%
14d5+0.00%-7.76%-0.41%-7.35%-6.24%
30d5+40.00%-2.68%+0.21%-2.89%-0.65%
60d5+20.00%-11.60%+2.15%-13.76%-10.63%
90d5+40.00%-9.43%+3.55%-12.98%-9.82%
180d5+60.00%+1.74%+10.44%-8.70%-9.13%
1y5+60.00%+17.60%+21.48%-3.88%-14.74%
2y5(2 pending)+33.33%-40.96%+50.43%-91.39%-117.85%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AYTU · 184,703 shares · as of Oct 3, 2025
0307,969615,939923,9081,231,87720212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 13 buys / 1 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
22,500207,203Oct 3, 2025Oct 7, 2025View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
31,446184,703Oct 3, 2025Oct 7, 2025View →
AYTU
AYTU BIOPHARMA, INC
PURCHASE
Chief Executive Officer
66,666$1.50$100.0K153,257Jun 9, 2025Jun 10, 2025View →
AYTU
AYTU BIOPHARMA, INC
PURCHASE
Chief Executive Officer
15,000$1.30$19.5K86,591Feb 28, 2025Mar 3, 2025View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
38,00038,000Nov 6, 2024Nov 8, 2024View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
35,00035,000Aug 11, 2023Aug 15, 2023View →
AYTU
AYTU BIOPHARMA, INC
PURCHASE
Chief Executive Officer
14,000$1.86$26.1K71,591Jun 14, 2023Jun 15, 2023View →
AYTU
AYTU BIOPHARMA, INC
SALE
Chief Executive Officer
80,0001,151,877Dec 20, 2022Dec 23, 2022View →
AYTU
AYTU BIOPHARMA, INC
PURCHASE
Chief Executive Officer
112,371$0.22$25.0K1,231,877Dec 19, 2022Dec 20, 2022View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
222,000$0.24$52.6K1,119,506Nov 18, 2022Nov 21, 2022View →
AYTU
AYTU BIOPHARMA, INC
PURCHASE
Chief Executive Officer
222,000$0.24$52.6K1,119,506Nov 18, 2022Nov 28, 2022View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
800,000897,506Apr 16, 2021Apr 16, 2021View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
450,000975,048Jun 8, 2020Jun 12, 2020View →
AYTU
AYTU BIOPHARMA, INC
PURCHASEGRANT
Stock grant
100,000100,275Jun 8, 2020Jun 12, 2020View →
Other insiders · AYTU
Loading peer insiders…
About this filer
CIK 0001566240
ROLE
Chief Executive Officer
PRIMARY
AYTU
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001566240DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback